A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of Utah Orthopaedic Innovation Center (OIC), Department of Orthopaedics and Spencer Fox Eccles School of Medicine announced on July 20, 2023.
Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial
Exscientia has backed the CDK7 candidate as the company “believes GTAEXS617 has the potential to overcome significant safety and efficacy limitations of existing approved treatments”.
July 19, 2024